Hormone Health9 min read·Published November 19, 2026

Premature Ovarian Failure HRT: Benefits and Safety

How estradiol, progesterone, bone health, fertility, and clinician-guided care fit into primary ovarian insufficiency.

Premature Ovarian Failure HRT: Benefits and Safety

Hormone replacement therapy may help replace low estrogen in premature ovarian failure, now usually called primary ovarian insufficiency (POI). It can support bone and overall health until the usual age of menopause for people without contraindications, but the hormone type, route, progesterone need, and pregnancy plan require an individual clinician evaluation.7 8

Wondering if hormone therapy is right for you? Take the 3-min clinical quiz.

See if you qualify →

What does hormone replacement therapy mean for primary ovarian insufficiency?

Primary ovarian insufficiency (POI) means ovarian function declines before age 40. It can lead to irregular or absent periods, higher follicle-stimulating hormone (FSH), and estrogen deficiency, but it does not always mean ovarian activity has ended permanently.8

The older term “premature ovarian failure” or POF still appears in studies and online searches. POI is now preferred because ovarian activity can be intermittent, and some people with POI can ovulate or become pregnant.8

A clinician usually evaluates missed or irregular periods, symptoms, pregnancy possibility, medicines, medical history, and hormone testing. Other causes of absent periods can look similar, so symptoms alone cannot confirm POI.8

Why can primary ovarian insufficiency affect health beyond periods?

POI can affect more than menstrual cycles because estrogen deficiency can affect bone and heart health over decades. Estrogen also has roles in the brain, vagina, urinary tract, and temperature regulation.7 8

Estrogen, symptoms, and bone health

Low estrogen can contribute to hot flashes, night sweats, vaginal dryness, sleep changes, and lower bone mineral density. Bone mineral density is a scan-based measure of bone strength, not a symptom you can feel.7 8

Hormone therapy is one evidence-based part of care when it is safe for the individual. Weight-bearing activity, adequate nutrition, avoiding smoking, and bone-health assessment may also be part of a clinician’s plan.8

Fertility and intermittent ovarian activity

POI is different from natural menopause because ovarian function may come and go. Pregnancy is possible, so anyone who does not want pregnancy needs a separate contraception conversation; hormone therapy itself should not be assumed to prevent pregnancy.8

What hormones may be included in POI treatment?

POI hormone treatment commonly centers on estradiol, a form of estrogen, with progesterone added for many people who have a uterus. The goal is hormone replacement, not a one-size-fits-all prescription.7 8

Estradiol: a form of estrogen

Estradiol is the main estrogen made during the reproductive years. In a randomized trial of women with hypergonadotropic amenorrhea, a condition involving high FSH and absent periods, estradiol replacement was studied as a way to replace estrogen; that population is relevant to POI but does not represent every person with POI.5

Estrogen can cause side effects such as breast tenderness, headache, nausea, or bleeding changes. A history of certain blood clots, stroke, estrogen-sensitive cancer, liver disease, or unexplained vaginal bleeding can change whether estrogen is appropriate.7 8

Why progesterone may be considered with a uterus

For a person with a uterus, progesterone or another progestogen is generally used alongside systemic estrogen to protect the endometrium, the lining of the uterus, from estrogen-driven overgrowth.7 8

Progesterone can cause sleepiness, dizziness, mood changes, breast tenderness, or spotting. A small 2001 randomized study examined psychological side effects with natural vaginal progesterone, but its findings were preliminary and cannot predict side effects from every progesterone product or route.2

How hormone routes differ

Estradiol may be prescribed by oral, skin-based, or other routes. The route can affect convenience, absorption, bleeding patterns, and risk considerations, so clinicians match the option to symptoms, medical history, and patient preferences rather than choosing one route for everyone.7 8

Situation or priorityDiscussion a clinician may haveImportant trade-off
POI with low estrogen and no major contraindicationWhether estrogen replacement is appropriate and which route fitsBenefits and risks depend on your history, not diagnosis alone
Uterus present with systemic estrogenWhether endometrial protection with progesterone is neededProgesterone can cause side effects and may affect bleeding patterns
Pregnancy is possible or desiredFertility counseling and a pregnancy planHRT is not reliable contraception
History of clotting, cancer, liver disease, or unexplained bleedingWhether hormones are appropriate or need specialist inputA different plan or more evaluation may be needed
Concern about bone healthBone-density assessment and broader bone-health careA scan and risk factors guide follow-up

What does evidence say about HRT and birth control pills for POI?

A small randomized trial found better lumbar-spine bone mineral density outcomes over two years with HRT than with a combined oral contraceptive pill in women with premature ovarian failure. This result is useful, but it does not identify one best regimen for every person.4

The 2016 trial compared hormone replacement therapy with a combined oral contraceptive pill, which contains estrogen and progestin and is also used for contraception. The study was limited in size, and its findings should not be stretched to all formulations, routes, ages, or medical histories.4

A combined oral contraceptive may be considered when contraception is also needed. Hormone therapy may be considered when the care goal is physiologic hormone replacement. Both choices have possible side effects and contraindications, including clotting-related concerns for some people, so a clinician should weigh the full picture.7 8

Other studies add context but do not settle the question. A 2025 randomized trial tested Kuntai capsule alongside HRT in people described as having POF and measured bone-metabolism outcomes; it does not show that supplements can replace clinician-guided hormone therapy.3

3-min quiz

Talk through your hormone options with a licensed provider

Chia offers an online evaluation for people exploring estradiol or progesterone. A prescription requires a medical evaluation and is not guaranteed. Medications supplied through Chia are compounded by US state-licensed 503A pharmacies and are not FDA-approved.

How do clinicians choose an HRT plan for primary ovarian insufficiency?

Clinicians choose a POI hormone plan by reviewing your symptoms, uterus status, pregnancy plans, and medical history. Follow-up matters because bleeding, side effects, symptom control, and life changes can alter the balance of benefits and risks.7 8

They may also review blood-pressure history, migraine history, clotting risk, smoking, cancer history, liver health, medicines, and bone health. A prospective study of artificial cycles found that endometrial responses varied across estrogen regimens, which helps explain why regimen decisions are clinician-guided rather than standardized for every patient.1

What changes over time?

Early follow-up often focuses on side effects, bleeding changes, and whether symptoms are improving. Over time, clinicians may reassess bone health, contraception needs, fertility goals, and whether the regimen still fits your health history.7 8

Do not start, stop, or change estradiol or progesterone on your own. This is especially important if pregnancy is possible, you develop new bleeding, or your health history changes.7 8

Who may need extra caution or a different treatment plan?

People with a history of blood clots, hormone-sensitive cancer, liver disease, or unexplained bleeding may need more evaluation before hormone treatment. The safest option depends on the condition, prior treatment, and the specific hormone under consideration.7 8

Seek prompt medical care for chest pain, shortness of breath, coughing blood, one-sided leg swelling or pain, sudden severe headache, weakness on one side, trouble speaking, or heavy unexplained vaginal bleeding. These symptoms can have serious causes and should not be managed through routine messaging alone.7

What could HRT treatment at Chia look like after an evaluation?

At Chia, a licensed US provider can review whether compounded estradiol or progesterone may fit your situation after an online health questionnaire. POI requires individualized evaluation, and a prescription is never guaranteed.

Chia currently offers compounded estradiol as cream, tablets, a transdermal patch, or injection. We offer compounded progesterone as cream or tablets. Plans currently start at $74.50 per month for estradiol and $109 per month for progesterone; see each product page for current details.

Chia optionForms currently offeredWhat the provider reviews
Compounded estradiolCream, tablets, transdermal patch, injectionSymptoms, medical history, route preferences, and contraindications
Compounded progesteroneCream, tabletsWhether endometrial protection may be needed and relevant risks
Menopause Relief protocolEstradiol oral plus progesterone IRWhether the protocol is clinically appropriate for your needs

If a provider prescribes treatment, medication is compounded in the United States by a state-licensed 503A compounding pharmacy and shipped to your door. Your care team can be contacted through the patient portal for provider-guided follow-up. Our Menopause Relief protocol is one listed option, but its suitability for POI must be decided by the evaluating provider.

If you are comparing care options, our guides to early menopause and hormone replacement, how to get HRT, and estrogen HRT side effects can help you prepare for that conversation.

What questions should you ask before starting or changing HRT?

Ask why POI is suspected, what testing is needed, and whether pregnancy prevention or fertility support belongs in your plan now. Clear questions can help you and your clinician make decisions without assuming that one approach fits everyone.8

  • What else could be causing missed or irregular periods?
  • Do I need progesterone based on whether I have a uterus and the estrogen route being considered?
  • What side effects or warning signs should prompt urgent care?
  • How will we monitor bone health and follow-up over time?
  • Does my plan need separate contraception or fertility counseling?
  • How do my personal or family history and current medicines affect my options?

3-min quiz

Start with a clinician-reviewed online visit

If you are exploring hormone care, Chia’s online questionnaire starts a licensed-provider review. A prescription requires a medical evaluation and is not guaranteed; your provider can decide whether compounded estradiol or progesterone is appropriate for you.

Frequently asked questions about POI and HRT

References

  1. 1.Li TC, Cooke ID, Warren MA, et al. Endometrial responses in artificial cycles: a prospective study comparing four different oestrogen dosages. British Journal of Obstetrics and Gynaecology. 1992.
  2. 2.Shantha S, Brooks-Gunn J, Locke RJ, et al. Natural vaginal progesterone is associated with minimal psychological side effects: a preliminary study. Journal of Women's Health & Gender-Based Medicine. 2001.
  3. 3.Shen A, Ren Y, Ling J, et al. Effects of kuntai capsule in combination with hormone replacement therapy on premature ovarian failure and bone metabolism. African Journal of Reproductive Health. 2025.
  4. 4.Cartwright B, Robinson J, Seed PT, et al. Hormone Replacement Therapy Versus the Combined Oral Contraceptive Pill in Premature Ovarian Failure: A Randomized Controlled Trial of the Effects on Bone Mineral Density. Journal of Clinical Endocrinology and Metabolism. 2016.
  5. 5.Taylor AE, Adams JM, Mulder JE, et al. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. Journal of Clinical Endocrinology and Metabolism. 1996.
  6. 6.Li TC, Dalton C, Bolton AE, et al. An analysis of the variation of plasma concentrations of placental protein 14 in artificial cycles. Fertility and Sterility. 1992.
  7. 7.American College of Obstetricians and Gynecologists. Hormone Therapy in Primary Ovarian Insufficiency. Committee Opinion No. 698. Obstetrics & Gynecology. 2017.
  8. 8.European Society of Human Reproduction and Embryology, American Society for Reproductive Medicine, and International Menopause Society. Evidence-based guideline: premature ovarian insufficiency. Human Reproduction Open. 2024.

About this article

Chia Health Editorial Team — Evidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

See if hormone therapy is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides